bt_bb_section_bottom_section_coverage_image
https://www.insitugen.com/wp-content/uploads/2022/03/Berlinger_InsituGen_announcement_post-img.jpg

BERLINGER PARTNERS WITH DIAGNOSTICS COMPANY INSITUGEN TO EXPAND ITS PROVEN ANTI-DOPING EQUIPMENT PORTFOLIO As part of its commitment to supporting clean sports worldwide, Swiss-based Berlinger Special AG, a global market leader in doping control equipment, today announced a strategic partnership with New Zealand company, InsituGen Ltd. InsituGen has developed an innovative assay – FIRSTFLAGXTM, for...

https://www.insitugen.com/wp-content/uploads/2020/07/post14.jpg

The Gluck Equine Research Foundation at the University of Kentucky is developing an equine biological passport with the goal of identifying specific biomarkers that will detect drug use by monitoring changes to peptides and protein abundance, and monitor those biomarkers over time, they announced Monday via press release. In simple terms, an EBP would track...